In the News

There is so much information that is being published daily about the pharmaceutical industry and your right to safe and affordable prescription drugs. Take a look at the articles below. Make sure to take a moment and let us know your thoughts.

Did we miss something? If you have a great story or a lead on a local article, please contact us.

Breakup of Physician, Drug Company Relationship Could Improve Health Care, Cut Cost

posted Tue, 21 May 2013

May 20, 2013
ScienceDaily

A new report suggests that improved health care and significant reductions in drug costs might be attained by breaking up the age-old relationship between physicians and drug company representatives who promote the newest, more costly and often unnecessary prescription drugs. Read more

 

 

 

Patent wars: has India taken on Big Pharma and won?

posted Wed, 15 May 2013

May 15, 2013
The Guardian
By Tim Smedley

It all seemed to be going so well for the big pharmaceutical companies (Big Pharma).

National governments used to be able to choose whether to grant patents on pharmaceutical products or not. Some countries such as India didn't award any patents at all, literally giving generics drugs companies free licence to copy lifesaving drugs at affordable prices. Then the World Trade Organization's (WTO) agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) came into force, effectively handing Big Pharma exclusive patents in all markets as of 2005. Read more

U.S. prescription drug spending drops for first time in 58 years

posted Fri, 10 May 2013

May 9, 2013
CBSnews.com

Americans spent less money on prescription drugs in 2012, the first time in almost six decades U.S. spending on prescription medication has dropped. Read more

We The People vs. The Pharmaceutical Industry

posted Mon, 29 Apr 2013

April 29, 2013
Forbes
By Bernard Munos

The pharma industry is in a pickle.  It is losing all its friends and handing over sticks to its enemies.  In the last few weeks:

  •     Novartis lost a major patent dispute in India
  •     Merck was denied an injunction against a generic Januvia
  •     South Africa announced plans to tighten its patenting requirements to deny IP protection to incremental innovations, often used by drug companies to “evergreen” their patents
  •     Germany extended the application of its much-hated pricing formula to the country’s most popular drugs
  •     100 leading oncologists have risen against drug prices, accusing the industry of having lost its moral compass, and demanding major price cuts

Read more

Doctors Denounce Cancer Drug Prices of $100,000 a Year

posted Fri, 26 Apr 2013

April 25, 2013
The New York Times
By Andrew Pollack

With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual step of banding together in hopes of persuading some leading pharmaceutical companies to bring prices down. Read more

 


Pages:  1 2 3 4 5 6 7 8 9 Last ›

Tell Us Your Thoughts

How do you feel about having to pay more than everyone else for your medication? Tell us your story. **By filling out this form you are giving RxRights permission to use your comments to help build support for safe, affordable drug importation.**

Recent Entries: